NATURAL UV W/ 326 NATURAL UV W/ SHELFPLUS BLUE BOTTLE HDPE

BLACK PP CAP W/CLIP NYL COYOTE BROWN UV PEPPER RED HDPE

These expanded offerings add medical-grade LDPE, nylon, PEBA, PS and PVC to the globally available palette of specialty healthcare colorants, and are pre-certified to meet or exceed biocompatibility requirements for ISO 10993 and/or USP Class VI protocols. All thirteen medical-grade carrier materials in the portfolio are pre-certified to meet or exceed ISO 10993 and/or USP Class VI requirements for applications ranging from medical packaging to device housings. 

SL BLUE CO-PP UV SL RED CO-PP UV GRAPHITE GRAY ABS GP22

YELLOW HDPE W/ PEARL XGF 1200 A 55 HS UV BLACK UV ORANGE HOLDER

YELLOW 109C HDPE W/ PEARL TRADER MELON w/TALC BLACK HDPE 3 S/P

TR BLUE ENGAGE UV WHITE W/ AO GREY LM HDPE V4

OFC TECHNOLOGY LEADER M I C R O B U N D L E S I N B L O W I N G A P P L I C A T I O N F O R R A I L W A Y S • Strippable with fingers for easy installation/access to fibers • High speed processing at a low wall thickness • Low shrinkage • Resistance to chemicals and filling compounds • Meet XP C93-850-1-1 standard • Re-designed cable to provide advantageous functional and economical value • Improved flexibility compared to PBT and PP tubes, allowing longer blowing distances on paths with angles of 90° • Increased processing speed and improved ease of installation • Provided better cable lifetime value compared to alternative solutions ECCOH™ 6151 UV SEPAP Formulation KEY REQUIREMENTS WHY AVIENT?

NEU™ Custom Capabilities and NEUSoft™ Thermoplastic Polyurethanes are developed for short-term in-vivo applications that offer good elasticity, radiopacity, excellent UV stability and protection against moisture and oxygen while meeting ISO 10993 & USP Class VI standards.

W H AT W E D O : W E A R E A F O R M U L ATO R CUSTOM FORMULATION 6 N O V E M B E R 2 , 2 0 2 3 W E B C A S T P R E S E N T AT I O N Complementary technologies and customer relationships offer opportunity to advance commercial strategy Dyneema®, the world’s strongest fiber™, to accelerate growth of sustainable, ultralight and high performance applications AVIENT PROTECTIVE MATERIALS FIRST YEAR 8 Composites comprises over half of Specialty Engineered Materials, compared to 9% in 2016 Proven history of success in areas such as outdoor high performance, defense and sustainable solutions Composites 44% 56% 2023E Sales Collaboration & InnovationComposites as a % of SEM People & Culture Talented, passionate, and creative associates drive continued integration success and allow two cultures to come together as one Avient Lightweight Protective Laminates: PROJECTILE PROTECTION Dyneema® Fiber Solutions Cushioning + Fit + Comfort: LONG-TERM WEAR reSound™ Versaflex™ Thermoplastic Elastomers Strength + Durability + Light-Weighting: SOLID MOUNTING BRACKETS Nymax™ Bergamid™ Complēt™ Engineered Materials Durability + Lubricity: HELMET LATCHES Lubri-One™ Internally Lubricated Polymers Color Consistency and Weatherability CUSTOMIZED SPECIFICATIONS Avient Color and Additive Solutions Antennae Performance FAST, RELIABLE CONNECTIONS PREPERM™ Low-Loss Dielectric Thermoplastics AVIENT PROTECTIVE MATERIALS C R O S S S E L L I N G O P P O R T U N I T I E S Wired Connections CONSTANT COMMUNICATION Syncure™ Cross-linkable Wire & Cable Formulations9 10 AVIENT PROTECTIVE MATERIALS C R O S S S E L L I N G O P P O R T U N I T I E S 10 Q 3 P E R F O R M A N C E 15.4% 16.3% 2022 PF 2023 Results vs. PRIOR YEAR $790 $710 2022 2023 $107 $112 2022 2023 Sales Adjusted EBITDA (in millions) $0.42 $0.47 2022 PF 2023 Adjusted EPS (in millions) - 10% + 5% + 12% Sales Adjusted EBITDA Adjusted EPS 16 $112 $500 Q4 FY $0.47 $2.30 Q4 FY Q4 AND FULL YEAR 2023 GUIDANCE $710 $3,130 Q4 FY Sales Adjusted EBITDA Adjusted EPS 17 (in millions) (in millions) Guidance: Free Cash Flow $180 $180 Prior Guidance Guidance FREE CASH FLOW & INCREASED DIVIDEND 13th Consecutive Dividend Increase 0.16 0.26 0.42 0.58 0.79 0.85 0.99 1.03 2011 2013 2015 2017 2019 2021 2023 2024 18 S U S T A I N A B I L I T Y D AY R E C A P SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS 60%+ Key Growth Drivers Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other (GDP Growth) Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other (GDP growth) 0–2% Avient 6% 20 SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 8-12% Long Term Growth 50 90 2022 2030 Medical Plastics Market Size (in $Billions) 2020 2030 Recycled Plastics Virgin Plastics Growing Demand for Recycled Content Avient Sustainable Solutions 18 46 2023 2032 Global Offshore Annual Wind Installations (in Gigawatts) Sources: McKinsey, Bloomberg, Grand View Research SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 21 • Transformative acquisitions combined with divestitures of more cyclical businesses have improved margins over 400 bps since 2018 • 20% long-term margin goal to be driven by key growth drivers, with sustainable solutions playing a meaningful role 5.4% 11.5% 16.0% 2006 2018 2023E Recovery Growth Drivers Strategic Objective 20%+ +1%+ +3%+ ADJUSTED EBITDA MARGIN EXPANSION 22 • 6% annualized long-term sales growth leveraging sustainable solutions, composites, healthcare, and emerging regions • Expand EBITDA margins to 20% • Deliver annual EBITDA and EPS growth of 10% and 15% • Maintain asset-light, 80% free cash flow conversion profile and be valued as a specialty formulator • Continue fostering our Great Place to Work® culture CRE AT ING A WORL D-CL AS S S US TAINABL E ORGANIZ AT ION 23 PEER COMPARISONS AVIENT IS ASSET LIGHT Capex / Revenue 2023E (%) Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of 2023年12月29日 Note: Avient reflects 2023 estimated revenue of $3,130 and estimated run-rate CAPEX of $110M. 26 3.5 1.8 2.7 3.1 3.3 3.7 3.0 3.7 4.7 4.8 6.8 6.8 8.7 11.1 A vi en t K W R FU L P P G A V Y R P M FM C H U N C E E C L H X L A S H E M N S C L FREE CASH FLOW CONVERSION Source: Peer data per Bloomberg as of 2023年12月29日 Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M. 2023E (%) 27 78 89 83 80 78 74 86 79 76 67 66 55 50 (39) A vi en t K W R FU L P P G A V Y R P M FM C C E E C L A S H H X L H U N E M N S C L Avient Specialty Formulators Other Specialty / Chemical Companies MULTIPLE EXPANSION Source: Peer data per Bloomberg as of 2023年12月29日 Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $41.57.